Prevalence of Congenital Anomalies in Iran

Ahmad Khaleghnejad-Tabari1, Saeed Dastgiri2, Hamid Soori3

  • 1Pediatric Surgery Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PubMed

Insights

Congenital anomalies affect 2.5% of births in Iran, with genital and limb defects being most common. This study provides crucial data for improving birth defect prevention and screening programs nationwide.

Area of Science:

  • Medical Epidemiology
  • Public Health
  • Genetics

Background:

  • Congenital anomalies impact 3-8 million infants globally each year.
  • Prevalence varies, ranging from 3% to 7% of births across different countries.
  • Understanding birth defect epidemiology in Iran is crucial for public health initiatives.

Purpose of the Study:

  • To investigate the nationwide epidemiological features of congenital anomalies in Iran.
  • To establish baseline data for birth defect prevalence and patterns.
  • To inform public health strategies for prevention and management.

Main Methods:

  • A cross-sectional study conducted across six major regions in Iran.
  • Data collected from maternity facilities affiliated with regional medical universities.
  • Newborns examined at birth and followed until discharge for congenital defects.

Main Results:

  • A total of 138,643 births were analyzed, with 3,458 cases of congenital anomalies.
  • The overall prevalence of congenital anomalies was 249.4 per 10,000 births.
  • Genital organ anomalies (92.7/10,000) and limb anomalies (83.3/10,000) were most prevalent.

Conclusions:

  • This study provides essential data on the burden of congenital anomalies in Iran.
  • Findings are vital for planning and evaluating antenatal screening programs.
  • Highlights the need for a national registry for congenital anomalies.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
250
Probability Laws01:49

Probability Laws

Overview
40.3K
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
282